Mega merger would disrupt Pfizer's AI transformation
他回答说，辉瑞将始终探索并购机会，但公司不计划推进大规模合并。布尔拉补充说，巨型合并带来的干扰会对公司执行人工智能（AI）转型产生负面影响。
English original
He replied that Pfizer will always explore merger and acquisition opportunities, but the company isn't planning to pursue a large-scale merger. Bourla added that the disruption of a mega merger would negatively affect the organization's execution of its artificial intelligence (AI) transformation.
在第一季度财报电话会上
原始出处
Pfizer's 6.5% Dividend Yield Looked Too Good to Be True -- but Management Just Silenced the Skeptics报道摘要
Pfizer CEO Albert Bourla addressed any doubts about the drugmaker's commitment to its dividend in the Q1 call, stating, "We intend to maintain and over time, grow our dividend as we continue to ...
The Motley Fool